Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.14 USD
Change Today +0.001 / 0.71%
Volume 52.0K
ASNB On Other Exchanges
As of 8:10 PM 10/9/15 All times are local (Market data is delayed by at least 15 minutes).

advansource biomaterials cor (ASNB) Snapshot

Previous Close
Day High
Day Low
52 Week High
08/28/15 - $0.17
52 Week Low
01/12/15 - $0.02
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

advansource biomaterials cor (ASNB) Related Businessweek News

No Related Businessweek News Found

advansource biomaterials cor (ASNB) Details

AdvanSource Biomaterials Corporation develops polymer materials for use in the design and development of medical devices used for treating a range of anatomical sites and disease states. It offers polymers under the ChronoFilm, ChronoFlex, ChronoThane, ChronoPrene, ChronoSil, HydroThane, HydroMed, and PolyBlend trade names. The company also manufactures specialty hydrophilic polyurethanes. The company sells its products directly to the customers in the United States. The company was formerly known as CardioTech International, Inc. and changed its name to AdvanSource Biomaterials Corporation in October 2008. AdvanSource Biomaterials Corporation was founded in 1993 and is headquartered in Wilmington, Massachusetts.

11 Employees
Last Reported Date: 07/14/15
Founded in 1993

advansource biomaterials cor (ASNB) Top Compensated Officers

Chief Executive officer, President, Treasurer...
Total Annual Compensation: $316.0K
Compensation as of Fiscal Year 2015.

advansource biomaterials cor (ASNB) Key Developments

AdvanSource Biomaterials Corporation Announces Earnings Results for the First Quarter Ended June 30, 2015

AdvanSource Biomaterials Corporation announced earnings results for the first quarter ended June 30, 2015. Total revenues for the three months ended June 30, 2015 were $1,171,000, compared with $621,000 for the comparable prior year period, an increase of $550,000, or 89%. Product sales of biomaterials for the three months ended June 30, 2015 were $1,048,000, compared with $366,000 for the comparable prior year period, an increase of $682,000, or 186%. License, royalty and development fees for the three months ended June 30, 2015 were $123,000, compared with $255,000 for the comparable prior year period, a decrease of $132,000 or 51%. Net income for the three month period ended June 30, 2015 was $377,000, compared with a net loss of $132,000 for the comparable prior year period.

AdvanSource Biomaterials Corporation announced delayed annual 10-K filing

On 06/29/2015, AdvanSource Biomaterials Corporation announced that they will be unable to file their next 10-K by the deadline required by the SEC.

Advansource Biomaterials Corporation Announces Resignation of David Volpe as Chief Financial Officer

On December 8, 2014, Mr. David Volpe resigned as the Chief Financial Officer of AdvanSource Biomaterials Corporation for personal reasons effective immediately.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ASNB:US $0.14 USD +0.001

ASNB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ASNB.
View Industry Companies

Industry Analysis


Industry Average

Valuation ASNB Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ADVANSOURCE BIOMATERIALS COR, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at